CD25 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD25" in French language version.

Last modified: 18:19:14, 4 April 2026 (UTC)

Ref.Un. Ref.Website

Global rank French rank

3826nih.gov

5^th place

11^th place

3523doi.org

2^nd place

3^rd place

73ensembl.org

630^th place

993^rd place

21uniprot.org

2,402^nd place

low place

11adsabs.harvard.edu

14^th place

54^th place

11genecards.org

low place

11europa.eu

62^nd place

68^th place

adsabs.harvard.edu (Global: 14^th place; French: 54^th place)

ui.adsabs.harvard.edu

« Localization of the gene encoding the human interleukin-2 receptor on chromosome 10 », Science, vol. 228, n^o 4707,‎ juin 1985, p. 1547–1549 (PMID 3925551, DOI 10.1126/science.3925551, Bibcode 1985Sci...228.1547L)

doi.org (Global: 2^nd place; French: 3^rd place)

dx.doi.org

« Biology and regulation of IL-2: from molecular mechanisms to human therapy », Nature Reviews. Immunology, vol. 18, n^o 10,‎ octobre 2018, p. 648–659 (PMID 30089912, DOI 10.1038/s41577-018-0046-y)
« Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity », Cytokine & Growth Factor Reviews, vol. 67,‎ octobre 2022, p. 80–88 (PMID 35803833, DOI 10.1016/j.cytogfr.2022.06.003)
« Localization of the gene encoding the human interleukin-2 receptor on chromosome 10 », Science, vol. 228, n^o 4707,‎ juin 1985, p. 1547–1549 (PMID 3925551, DOI 10.1126/science.3925551, Bibcode 1985Sci...228.1547L)
« Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls », Cells, vol. 8, n^o 6,‎ juin 2019, p. 634 (PMID 31242590, PMCID 6628508, DOI 10.3390/cells8060634)
(en) « Association between interleukin 2 receptor A gene polymorphisms (rs2104286 and rs12722489) with susceptibility to multiple sclerosis in Iranian population », Meta Gene, vol. 25,‎ septembre 2020, p. 100750 (DOI 10.1016/j.mgene.2020.100750)
« Toward further mapping of the association between the IL2RA locus and type 1 diabetes », Diabetes, vol. 56, n^o 4,‎ avril 2007, p. 1174–1176 (PMID 17395754, DOI 10.2337/db06-1555)
« The type I diabetes association of the IL2RA locus », Genes and Immunity, vol. 10, n^o Suppl 1,‎ décembre 2009, S42-S48 (PMID 19956099, PMCID 2805446, DOI 10.1038/gene.2009.90)
« Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes », Nature Genetics, vol. 39, n^o 9,‎ septembre 2007, p. 1074–1082 (PMID 17676041, DOI 10.1038/ng2102)
« Natural Killer Cells: Development, Maturation, and Clinical Utilization », Frontiers in Immunology, vol. 9,‎ 13 août 2018, p. 1869 (PMID 30150991, PMCID 6099181, DOI 10.3389/fimmu.2018.01869)
« The IL-2A receptor pathway and its role in lymphocyte differentiation and function », Cytokine & Growth Factor Reviews, vol. 67,‎ octobre 2022, p. 66–79 (PMID 35803834, DOI 10.1016/j.cytogfr.2022.06.004)
« CD4+CD25-Foxp3+ T cells as a marker of disease activity and organ damage in systemic lupus erythematosus patients », Archives of Medical Science, vol. 14, n^o 5,‎ août 2018, p. 1033–1040 (PMID 30154885, PMCID 6111364, DOI 10.5114/aoms.2016.63597)
« Surface markers of lymphocyte activation and markers of cell proliferation », Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 413, n^os 17-18,‎ septembre 2012, p. 1338–1349 (PMID 22120733, DOI 10.1016/j.cca.2011.11.006)
« The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer », British Journal of Haematology, vol. 179, n^o 1,‎ octobre 2017, p. 20–35 (PMID 28556984, DOI 10.1111/bjh.14770)
« Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy », Clinical Cancer Research, vol. 10, n^o 16,‎ août 2004, p. 5587–5594 (PMID 15328201, DOI 10.1158/1078-0432.CCR-0721-03)
« Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity », Clinical Immunology, vol. 146, n^o 3,‎ mars 2013, p. 248–261 (PMID 23416241, PMCID 3594590, DOI 10.1016/j.clim.2013.01.004)
« The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis », Journal of Translational Autoimmunity, vol. 4,‎ 2021, p. 100123 (PMID 35005590, PMCID 8716671, DOI 10.1016/j.jtauto.2021.100123)
« Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act », Frontiers in Immunology, vol. 9,‎ 20 décembre 2018, p. 2987 (PMID 30619342, DOI 10.3389/fimmu.2018.02987)
« The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor », Clinical Immunology, vol. 218,‎ septembre 2020, p. 108515 (PMID 32619646, DOI 10.1016/j.clim.2020.108515)
« Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma », Blood, vol. 104, n^o 10,‎ novembre 2004, p. 3355–3357 (PMID 15205267, DOI 10.1182/blood-2003-11-3922)
« Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019 », International Journal of Infectious Diseases, vol. 105,‎ avril 2021, p. 522–524 (PMID 33711520, PMCID 7942057, DOI 10.1016/j.ijid.2021.03.011)
« Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment », Frontiers in Microbiology, vol. 7,‎ 13 mai 2016, p. 675 (PMID 27242702, PMCID 4866556, DOI 10.3389/fmicb.2016.00675)
« An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer », Nature Communications, vol. 11, n^o 1,‎ décembre 2020, p. 6440 (PMID 33353953, PMCID 7755894, DOI 10.1038/s41467-020-20220-1)
« Daclizumab (anti-CD25) in multiple sclerosis », Experimental Neurology, vol. 262 Pt A,‎ décembre 2014, p. 44–51 (PMID 24768797, DOI 10.1016/j.expneurol.2014.04.015)

ensembl.org (Global: 630^th place; French: 993^rd place)

may2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000134460 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000026770 - Ensembl, May 2017

ensembl.org

« Gene: IL2RA (ENSG00000134460) - Orthologues - Homo_sapiens - Ensembl genome browser 108 », www.ensembl.org (consulté le 25 janvier 2023)

europa.eu (Global: 62^nd place; French: 68^th place)

ema.europa.eu

« Zinbryta Summary of Product Characteristics », European Medicines Agency, 2016

genecards.org (Global: low place; French: low place)

« IL2RA Gene - GeneCards | IL2RA Protein | IL2RA Antibody », www.genecards.org (consulté le 25 janvier 2023)

nih.gov (Global: 5^th place; French: 11^th place)

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Biology and regulation of IL-2: from molecular mechanisms to human therapy », Nature Reviews. Immunology, vol. 18, n^o 10,‎ octobre 2018, p. 648–659 (PMID 30089912, DOI 10.1038/s41577-018-0046-y)
« Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity », Cytokine & Growth Factor Reviews, vol. 67,‎ octobre 2022, p. 80–88 (PMID 35803833, DOI 10.1016/j.cytogfr.2022.06.003)
« Localization of the gene encoding the human interleukin-2 receptor on chromosome 10 », Science, vol. 228, n^o 4707,‎ juin 1985, p. 1547–1549 (PMID 3925551, DOI 10.1126/science.3925551, Bibcode 1985Sci...228.1547L)
« Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls », Cells, vol. 8, n^o 6,‎ juin 2019, p. 634 (PMID 31242590, PMCID 6628508, DOI 10.3390/cells8060634)
« Toward further mapping of the association between the IL2RA locus and type 1 diabetes », Diabetes, vol. 56, n^o 4,‎ avril 2007, p. 1174–1176 (PMID 17395754, DOI 10.2337/db06-1555)
« The type I diabetes association of the IL2RA locus », Genes and Immunity, vol. 10, n^o Suppl 1,‎ décembre 2009, S42-S48 (PMID 19956099, PMCID 2805446, DOI 10.1038/gene.2009.90)
« Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes », Nature Genetics, vol. 39, n^o 9,‎ septembre 2007, p. 1074–1082 (PMID 17676041, DOI 10.1038/ng2102)
(en) « IL2RA interleukin 2 receptor subunit alpha [Homo sapiens (human)] - Gene - NCBI », www.ncbi.nlm.nih.gov (consulté le 25 janvier 2023)
« Natural Killer Cells: Development, Maturation, and Clinical Utilization », Frontiers in Immunology, vol. 9,‎ 13 août 2018, p. 1869 (PMID 30150991, PMCID 6099181, DOI 10.3389/fimmu.2018.01869)
« The IL-2A receptor pathway and its role in lymphocyte differentiation and function », Cytokine & Growth Factor Reviews, vol. 67,‎ octobre 2022, p. 66–79 (PMID 35803834, DOI 10.1016/j.cytogfr.2022.06.004)
« CD4+CD25-Foxp3+ T cells as a marker of disease activity and organ damage in systemic lupus erythematosus patients », Archives of Medical Science, vol. 14, n^o 5,‎ août 2018, p. 1033–1040 (PMID 30154885, PMCID 6111364, DOI 10.5114/aoms.2016.63597)
« Surface markers of lymphocyte activation and markers of cell proliferation », Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 413, n^os 17-18,‎ septembre 2012, p. 1338–1349 (PMID 22120733, DOI 10.1016/j.cca.2011.11.006)
« The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer », British Journal of Haematology, vol. 179, n^o 1,‎ octobre 2017, p. 20–35 (PMID 28556984, DOI 10.1111/bjh.14770)
« Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy », Clinical Cancer Research, vol. 10, n^o 16,‎ août 2004, p. 5587–5594 (PMID 15328201, DOI 10.1158/1078-0432.CCR-0721-03)
« Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity », Clinical Immunology, vol. 146, n^o 3,‎ mars 2013, p. 248–261 (PMID 23416241, PMCID 3594590, DOI 10.1016/j.clim.2013.01.004)
« The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis », Journal of Translational Autoimmunity, vol. 4,‎ 2021, p. 100123 (PMID 35005590, PMCID 8716671, DOI 10.1016/j.jtauto.2021.100123)
« Entrez Gene: IL2RA interleukin 2 receptor, alpha »
« Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act », Frontiers in Immunology, vol. 9,‎ 20 décembre 2018, p. 2987 (PMID 30619342, DOI 10.3389/fimmu.2018.02987)
« The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor », Clinical Immunology, vol. 218,‎ septembre 2020, p. 108515 (PMID 32619646, DOI 10.1016/j.clim.2020.108515)
« Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma », Blood, vol. 104, n^o 10,‎ novembre 2004, p. 3355–3357 (PMID 15205267, DOI 10.1182/blood-2003-11-3922)
« Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019 », International Journal of Infectious Diseases, vol. 105,‎ avril 2021, p. 522–524 (PMID 33711520, PMCID 7942057, DOI 10.1016/j.ijid.2021.03.011)
« Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment », Frontiers in Microbiology, vol. 7,‎ 13 mai 2016, p. 675 (PMID 27242702, PMCID 4866556, DOI 10.3389/fmicb.2016.00675)
« An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer », Nature Communications, vol. 11, n^o 1,‎ décembre 2020, p. 6440 (PMID 33353953, PMCID 7755894, DOI 10.1038/s41467-020-20220-1)
« Daclizumab (anti-CD25) in multiple sclerosis », Experimental Neurology, vol. 262 Pt A,‎ décembre 2014, p. 44–51 (PMID 24768797, DOI 10.1016/j.expneurol.2014.04.015)

uniprot.org (Global: 2,402^nd place; French: low place)

« UniProt », www.uniprot.org (consulté le 25 janvier 2023)